Association of EGF rs4444903 and XPD rs13181 polymorphisms with cutaneous melanoma in Caucasians

Medicinal Chemistry

Volumn 11, Issue 6, 2015, Pages 551-559

  Liu, Jun ^a   Song, Jia ^a,b   Wang, Mei Yan ^c   He, Lin ^a   Cai, Lei ^a,e   Chou, Kuo Chen ^d,e  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Department of Plastic Surgery   (China)

^c TONGJI UNIVERSITY   (China)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e GORDON LIFE SCIENCE INSTITUTE   (United States)

Author keywords

Cutaneous melanoma; EGF; SNP; XPD

Indexed keywords

EPIDERMAL GROWTH FACTOR; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ARTICLE; CANCER SUSCEPTIBILITY; CAUCASIAN; CUTANEOUS MELANOMA; EXCISION REPAIR; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CARCINOGENESIS; ULTRAVIOLET RADIATION; GENETIC POLYMORPHISM; GENETICS; MELANOMA; SKIN TUMOR;

EPIDERMAL GROWTH FACTOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MELANOMA; POLYMORPHISM, GENETIC; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84938792871     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406410666141224115516     Document Type: Article

References (86)

1. Rigel, D. S.; Russak, J.; Friedman, R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J. Clin., 2010, 60, 301-316.
2. Kirkwood, J. M.; Tarhini, A. A.; Panelli, M. C.; Moschos, S. J.; Zarour, H. M.; Butterfield, L. H.; Gogas, H. J. Next generation of immunotherapy for melanoma. J. Clin. Oncol., 2008, 26, 3445-3455.
3. Chin, L.; Garraway, L. A.; Fisher, D. E. Malignant melanoma: genetics and therapeutics in the genomic era. Genes Develop., 2006, 20, 2149-2182.
4. Mitra, D.; Luo, X.; Morgan, A.; Wang, J.; Hoang, M. P.; Lo, J.; Guerrero, C. R.; Lennerz, J. K.; Mihm, M. C.; Wargo, J. A.; Robinson, K. C.; Devi, S. P.; Vanover, J. C.; D'Orazio, J. A.; McMahon, M.; Bosenberg, M. W.; Haigis, K. M.; Haber, D. A.; Wang, Y.; Fisher, D. E. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature, 2012, 491, 449-453.
5. Diaz-Lagares, A.; Alegre, E.; Arroyo, A.; Gonzalez-Cao, M.; Zudaire, M. E.; Viteri, S.; Martin-Algarra, S.; Gonzalez, A. Evaluation of multiple serum markers in advanced melanoma. Tumour Biol., 2011, 32, 1155-1161.
6. Vizkeleti, L.; Ecsedi, S.; Rakosy, Z.; Orosz, A.; Lazar, V.; Emri, G.; Koroknai, V.; Kiss, T.; Adany, R.; Balazs, M. The role of CCND1 alterations during the progression of cutaneous malignant melanoma. Tumour Biol., 2012, 33, 2189-2199.
7. Mitchell, D. L.; Fernandez, A. A. Different types of DNA damage play different roles in the etiology of sunlight-induced melanoma. Pigment Cell Melanoma Res., 2011, 24, 119-124.
8. Ransom, M.; Dennehey, B. K.; Tyler, J. K. Chaperoning histones during DNA replication and repair. Cell, 2010, 140, 183-195.
9. Benhamou, S.; Sarasin, A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis, 2002, 17, 463-469.
10. Xue, H.; Lu, Y.; Lin, B.; Chen, J.; Tang, F.; Huang, G. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. PloS One, 2012, 7, e43431.
11. Carpenter, G.; Cohen, S. Epidermal growth factor. J. Biol. Chem., 1990, 265, 7709-7712.
12. Lazar-Molnar, E.; Hegyesi, H.; Toth, S.; Falus, A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine, 2000, 12, 547-554.
13. Shahbazi, M.; Pravica, V.; Nasreen, N.; Fakhoury, H.; Fryer, A. A.; Strange, R. C.; Hutchinson, P. E.; Osborne, J. E.; Lear, J. T.; Smith, A. G.; Hutchinson, I. V. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet, 2002, 359, 397-401.
14. Chou, K. C. Impacts of bioinformatics to medicinal chemistry. Med. Chem., 2015, 11, 218-234.
15. a) Chu, W. Z.; Gong, L.; Xu, Y. Q.; Cai, G. H.; Chou, K. C. Apolipoprotein E gene variants of Alzheimer's disease and vascular dementia patients in a community population of nanking. Med. Chem., 2014, 10, 783-788;
16. Jones, D.; Heinrikson, R. L. Prediction of the tertiary structure and substrate binding site of caspase-8. FEBS Lett., 1997, 419, 49-54;
17. Tomasselli, A. G.; Heinrikson, R. L. Prediction of the Tertiary Structure of a Caspase-9/Inhibitor Complex. FEBS Lett., 2000, 470, 249-256.
18. Chou, K. C. Prediction of protein cellular attributes using pseudo amino acid composition. Proteins: Struct. Funct. Genet., (Erratum: ibid., 2001, Vol. 44, 60), 2001, 43, 246-255.
19. Chou, K. C. Using amphiphilic pseudo amino acid composition to predict enzyme subfamily classes. Bioinformatics, 2005, 21, 10-19.
20. Lin, S. X.; Lapointe, J. Theoretical and experimental biology in one-A symposium in honour of Professor Kuo-Chen Chou's 50th anniversary and Professor Richard Giegé's 40th anniversary of their scientific careers. J. Biomed. Sci. Eng. (JBiSE), 2013, 6, 435-442.
21. Du, P.; Wang, X.; Xu, C.; Gao, Y. PseAAC-Builder: A crossplatform stand-alone program for generating various special Chou's pseudo-amino acid compositions. Anal. Biochem., 2012, 425, 117-119.
22. Zhong, W. Z.; Zhou, S. F. Molecular science for drug development and biomedicine. Int. J. Mol. Sci., 2014, 15, 20072-20078.
23. Hajisharifi, Z.; Piryaiee, M.; Mohammad Beigi, M.; Behbahani, M.; Mohabatkar, H. Predicting anticancer peptides with Chou's pseudo amino acid composition and investigating their mutagenicity via Ames test. J. Theor. Biol., 2014, 341, 34-40.
24. Xiao, X.; Lin, W. Z.; Chou, K. C. Recent advances in predicting protein classification and their applications to drug development. Curr. Topics Med. Chem., 2013, 13, 1622-1635.
25. Xiao, X.; Wang, P.; Chou, K. C. Recent progresses in identifying nuclear receptors and their families. Curr. Topics Med. Chem., 2013, 13, 1192-1200.
26. Feng, P. M.; Chen, W.; Lin, H.; Chou, K. C. iHSP-PseRAAAC: Identifying the heat shock protein families using pseudo reduced amino acid alphabet composition. Anal. Biochem., 2013, 442, 118-125.
27. Min, J. L.; Xiao, X.; Chou, K. C. iEzy-Drug: A web server for identifying the interaction between enzymes and drugs in cellular networking. BioMed. Res. Int., 2013, 2013, 701317.
28. Xiao, X.; Min, J. L.; Wang, P.; Chou, K. C. iGPCR-Drug: A web server for predicting interaction between GPCRs and drugs in cellular networking. PLoS One, 2013, 8, e72234.
29. Xiao, X.; Min, J. L.; Wang, P.; Chou, K. C. iCDI-PseFpt: Identify the channel-drug interaction in cellular networking with PseAAC and molecular fingerprints. J. Theor. Biol., 2013, 337 C, 71-79.
30. Fan, Y. N.; Xiao, X.; Min, J. L.; Chou, K. C. iNR-Drug: Predicting the interaction of drugs with nuclear receptors in cellular networking. Int. J. Mol. Sci., 2014, 15, 4915-4937.
31. Ding, H.; Deng, E. Z.; Yuan, L. F.; Liu, L.; Lin, H.; Chen, W.; Chou, K. C. iCTX-Type: A sequence-based predictor for identifying the types of conotoxins in targeting ion channels. BioMed. Res. Int., 2014, 2014, 286419.
32. Dehzangi, A.; Heffernan, R.; Sharma, A.; Lyons, J.; Paliwal, K.; Sattar, A. Gram-positive and Gram-negative protein subcellular localization by incorporating evolutionary-based descriptors into Chou's general PseAAC. J. Theor. Biol., 2015, 364, 284-294.
33. Kumar, R.; Srivastava, A.; Kumari, B.; Kumar, M. Prediction of beta-lactamase and its class by Chou's pseudo-amino acid composition and support vector machine. J. Theor. Biol., 2015, 365, 96-103.
34. Khan, Z. U.; Hayat, M.; Khan, M. A. Discrimination of acidic and alkaline enzyme using Chou's pseudo amino acid composition in conjunction with probabilistic neural network model. J. Theor. Biol., 2015, 365, 197-203.
35. Xiao, X.; Min, J. L.; Lin, W. Z.; Liu, Z.; Cheng, X.; Chou, K. C. iDrug-Target: predicting the interactions between drug compounds and target proteins in cellular networking via the benchmark dataset optimization approach. J. Biomol. Struct. Dynam., (JBSD) 2014, doi: 10.1080/07391102.07392014.07998710.
36. Cao, D. S.; Xu, Q. S.; Liang, Y. Z. propy: a tool to generate various modes of Chou's PseAAC. Bioinformatics, 2013, 29, 960-962.
37. Du, P.; Gu, S.; Jiao, Y. PseAAC-General: Fast building various modes of general form of Chou's pseudo-amino acid composition for large-scale protein datasets. Int. J. Mol. Sci., 2014, 15, 3495-3506.
38. Xu, Y.; Wen, X.; Shao, X. J.; Deng, N. Y.; Chou, K. C. iHyd-PseAAC: Predicting hydroxyproline and hydroxylysine in proteins by incorporating dipeptide position-specific propensity into pseudo amino acid composition. Int. J. Mol. Sci., 2014, 15, 7594-7610.
39. Qiu, W. R.; Xiao, X.; Lin, W. Z.; Chou, K. C. iMethyl-PseAAC: Identification of Protein Methylation Sites via a Pseudo Amino Acid Composition Approach. Biomed. Res. Int., 2014, 2014, 947416.
40. Xu, Y.; Wen, X.; Wen, L. S.; Wu, L. Y.; Deng, N. Y.; Chou, K. C. iNitro-Tyr: Prediction of nitrotyrosine sites in proteins with general pseudo amino acid composition. PLoS One, 2014, 9, e105018.
41. Xu, Y.; Shao, X. J.; Wu, L. Y.; Deng, N. Y.; Chou, K. C. iSNOAAPair: incorporating amino acid pairwise coupling into PseAAC for predicting cysteine S-nitrosylation sites in proteins. PeerJ, 2013, 1, e171.
42. Xu, Y.; Ding, J.; Wu, L. Y.; Chou, K. C. iSNO-PseAAC: Predict cysteine S-nitrosylation sites in proteins by incorporating position specific amino acid propensity into pseudo amino acid composition. PLoS One, 2013, 8, e55844.
43. Qiu, W. R.; Xiao, X.; Lin, W. Z.; Chou, K. C. iUbiq-Lys: Prediction of lysine ubiquitination sites in proteins by extracting sequence evolution information via a grey system model. J. Biomol. Struct. Dynam. (JBSD) 2014, doi:10.1080/07391102.2014.968875.
44. Lin, W. Z.; Fang, J. A.; Xiao, X.; Chou, K. C. iDNA-Prot: Identification of DNA binding proteins using random forest with grey model. PLoS One, 2011, 6, e24756.
45. Liu, B.; Xu, J.; Lan, X.; Xu, R.; Zhou, J.; Wang, X.; Chou, K. C. iDNA-Prot|dis: identifying DNA-binding proteins by incorporating amino acid distance-pairs and reduced alphabet profile into the general pseudo amino acid composition. PLoS One, 2014, 9, e106691.
46. Chen, W.; Feng, P. M.; Lin, H.; Chou, K. C. iRSpot-PseDNC: identify recombination spots with pseudo dinucleotide composition. Nucleic Acids Res., 2013, 41, e68.
47. Qiu, W. R.; Xiao, X.; Chou, K. C. iRSpot-TNCPseAAC: Identify recombination spots with trinucleotide composition and pseudo amino acid components. Int. J. Mol. Sci, 2014, 15, 1746-1766.
48. Chen, W.; Lin, H.; Feng, P. M.; Ding, C.; Zuo, Y. C.; Chou, K. C. iNuc-PhysChem: A sequence-based predictor for identifying nucleosomes via physicochemical properties. PLoS One, 2012, 7, e47843.
49. Guo, S. H.; Deng, E. Z.; Xu, L. Q.; Ding, H.; Lin, H.; Chen, W.; Chou, K. C. iNuc-PseKNC: a sequence-based predictor for predicting nucleosome positioning in genomes with pseudo k-tuple nucleotide composition. Bioinformatics, 2014, 30, 1522-1529.
50. Lin, H.; Deng, E. Z.; Ding, H.; Chen, W.; Chou, K. C. iPro54-PseKNC: a sequence-based predictor for identifying sigma-54 promoters in prokaryote with pseudo k-tuple nucleotide composition. Nucleic Acids Res., 2014, 42, 12961-12972.
51. Liu, Z.; Xiao, X.; Qiu, W. R.; Chou, K. C. iDNA-Methyl: Identifying DNA methylation sites via pseudo trinucleotide composition. Anal. Biochem., 2015, 474, 69-77.
52. Chen, W.; Feng, P. M.; Lin, H.; Chou, K. C. iSS-PseDNC: identifying splicing sites using pseudo dinucleotide composition. Biomed. Res. Int., 2014, 2014, 623149.
53. Chen, W.; Feng, P. M.; Deng, E. Z.; Lin, H.; Chou, K. C. iTISPseTNC: a sequence-based predictor for identifying translation initiation site in human genes using pseudo trinucleotide composition. Anal. Biochem., 2014, 462, 76-83.
54. Chen, W.; Lei, T. Y.; Jin, D. C.; Lin, H.; Chou, K. C. PseKNC: a flexible web-server for generating pseudo K-tuple nucleotide composition. Anal. Biochem., 2014, 456, 53-60.
55. Chen, W.; Zhang, X.; Brooker, J.; Lin, H.; Zhang, L.; Chou, K. C. PseKNC-General: a cross-platform package for generating various modes of pseudo nucleotide compositions. Bioinformatics, 2014, doi:10.1093/bioinformatics/btu602.
56. Liu, B.; Liu, F.; Fang, L.; Wang, X.; Chou, K. C. repDNA: a Python package to generate various modes of feature vectors for DNA sequences by incorporating user-defined physicochemical properties and sequence-order effects. Bioinformatics, 2015, 31, 119-120.
57. Gloster, H. M., Jr.; Neal, K. Skin cancer in skin of color. J. Am. Acad. Dermatol., 2006, 55, 741-760; quiz 761-744.
58. Bradford, P. T. Skin cancer in skin of color. Dermatol. Nurs., 2009, 21, 170-177, 206; quiz 178.
59. Oxman, A. D.; Clarke, M. J.; Stewart, L. A. From science to practice. Meta-analyses using individual patient data are needed. JAMA. 1995, 274, 845-846.
60. Schumacher, M.; Rucker, G.; Schwarzer, G. Meta-analysis and the Surgeon General's report on smoking and health. N Engl. J. Med., 2014, 370, 186-188.
61. Lei, C.; Dongqing, Z.; Yeqing, S.; Oaks, M. K.; Lishan, C.; Jianzhong, J.; Jie, Q.; Fang, D.; Ningli, L.; Xinghai, H.; Daming, R. Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. Eur. J. Hum. Genet., 2005, 13, 823-828.
62. Kotelnikova, E.; Shkrob, M. A.; Pyatnitskiy, M. A.; Ferlini, A.; Daraselia, N. Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophy. PLoS Comput. Biol., 2012, 8, e1002365.
63. Schizophrenia Working Group of the Psychiatric Genomics, C. Biological insights from 108 schizophrenia-associated genetic loci. Nature, 2014, 511, 421-427.
64. Der Simonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials, 1986, 7, 177-188.
65. Mantel, N.; Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Nat. Cancer Inst., 1959, 22, 719-748.
66. Cai, L.; Deng, S. L.; Liang, L.; Pan, H.; Zhou, J.; Wang, M. Y.; Yue, J.; Wan, C. L.; He, G.; He, L. Identification of genetic associations of SP110/MYBBP1A/RELA with pulmonary tuberculosis in the Chinese Han population. Hum. Genet., 2013, 132, 265-273.
67. Cai, L.; Huang, W.; Chou, K. C. Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis. Protein pept. Lett., 2012, 19, 62-69.
68. Egger, M.; Davey Smith, G.; Schneider, M.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997, 315, 629-634.
69. Winsey, S. L.; Haldar, N. A.; Marsh, H. P.; Bunce, M.; Marshall, S. E.; Harris, A. L.; Wojnarowska, F.; Welsh, K. I. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res., 2000, 60, 5612-5616.
70. Povey, J. E.; Darakhshan, F.; Robertson, K.; Bisset, Y.; Mekky, M.; Rees, J.; Doherty, V.; Kavanagh, G.; Anderson, N.; Campbell, H.; MacKie, R. M.; Melton, D. W. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis, 2007, 28, 1087-1093.
71. Millikan, R. C.; Hummer, A.; Begg, C.; Player, J.; de Cotret, A. R.; Winkel, S.; Mohrenweiser, H.; Thomas, N.; Armstrong, B.; Kricker, A.; Marrett, L. D.; Gruber, S. B.; Culver, H. A.; Zanetti, R.; Gallagher, R. P.; Dwyer, T.; Rebbeck, T. R.; Busam, K.; From, L.; Mujumdar, U.; Berwick, M. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis, 2006, 27, 610-618.
72. Li, C.; Hu, Z.; Liu, Z.; Wang, L. E.; Strom, S. S.; Gershenwald, J. E.; Lee, J. E.; Ross, M. I.; Mansfield, P. F.; Cormier, J. N.; Prieto, V. G.; Duvic, M.; Grimm, E. A.; Wei, Q. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol. Biomarkers, Prev., 2006, 15, 2526-2532.
73. Kertat, K.; Rosdahl, I.; Sun, X. F.; Synnerstad, I.; Zhang, H. The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: a case control study in the Swedish population. Oncol. Reports, 2008, 20, 179-183.
74. Han, J.; Colditz, G. A.; Liu, J. S.; Hunter, D. J. Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol. Biomarkers, 2005, 14, 1539-1544.
75. Debniak, T.; Scott, R. J.; Huzarski, T.; Byrski, T.; Masojc, B.; van de Wetering, T.; Serrano-Fernandez, P.; Gorski, B.; Cybulski, C.; Gronwald, J.; Debniak, B.; Maleszka, R.; Kladny, J.; Bieniek, A.; Nagay, L.; Haus, O.; Grzybowska, E.; Wandzel, P.; Niepsuj, S.; Narod, S. A.; Lubinski, J. XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res. Treat., 2006, 98, 209-215.
76. Baccarelli, A.; Calista, D.; Minghetti, P.; Marinelli, B.; Albetti, B.; Tseng, T.; Hedayati, M.; Grossman, L.; Landi, G.; Struewing, J. P.; Landi, M. T. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br. J. Cancer, 2004, 90, 497-502.
77. Amend, K. L.; Elder, J. T.; Tomsho, L. P.; Bonner, J. D.; Johnson, T. M.; Schwartz, J.; Berwick, M.; Gruber, S. B. EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res., 2004, 64, 2668-2672.
78. Casula, M.; Alaibac, M.; Pizzichetta, M. A.; Bono, R.; Ascierto, P. A.; Stanganelli, I.; Canzanella, S.; Palomba, G.; Zattra, E.; Italian Melanoma, I.; Palmieri, G. Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. BMC Dermatol., 2009, 9, 7.
79. James, M. R.; Hayward, N. K.; Dumenil, T.; Montgomery, G. W.; Martin, N. G.; Duffy, D. L. Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia. J. Investig. Dermatol., 2004, 123, 760-762.
80. McCarron, S. L.; Bateman, A. C.; Theaker, J. M.; Howell, W. M. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int. J. Cancer, 2003, 107, 673-675.
81. Randerson-Moor, J. A.; Gaut, R.; Turner, F.; Whitaker, L.; Barrett, J. H.; SilvałIdos, S.; Swerdlow, A.; Bishop, D. T.; Bishop, J. A. The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility. J. Invest. Dermatol., 2004, 123, 755-759.
82. Fan, J. B.; Sklar, P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol. Psychiatry, 2005, 10, 928-938, 891.
83. Fisher, D. A.; Lakshmanan, J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr. Rev., 1990, 11, 418-442.
84. Tanabe, K. K.; Lemoine, A.; Finkelstein, D. M.; Kawasaki, H.; Fujii, T.; Chung, R. T.; Lauwers, G. Y.; Kulu, Y.; Muzikansky, A.; Kuruppu, D.; Lanuti, M.; Goodwin, J. M.; Azoulay, D.; Fuchs, B. C. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA, 2008, 299, 53-60.
85. Lieber, M. R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem., 2010, 79, 181-211.
86. Alberg, A. J.; Jorgensen, T. J.; Ruczinski, I.; Wheless, L.; Shugart, Y. Y.; Berthier-Schaad, Y.; Kessing, B.; Hoffman-Bolton, J.; Helzlsouer, K. J.; Kao, W. H.; Francis, L.; Alani, R. M.; Smith, M. W.; Strickland, P. T. DNA repair gene variants in relation to overall cancer risk: a population-based study. Carcinogenesis, 2013, 34, 86-92.